Cardiosense, Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced that it has raised $15.1 million in Series A funding. The round was co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint …
Aquaconnect, an India-based aquaculture management platform, secured $15 million in Series A funding. The round was led by Lok Capital, with participation from Louis Dreyfus Company Ventures and Suneight Investment. Existing investors AgFunder, Omnivore, Rebright Partners, Flourish Ventures, and HATCH, along with other debt investors, also participated. Aquaconnect will use …
SafeHouse Tech, a Tel Aviv, Israel-based cybersecurity startup, raised $6 million in pre-series A funding, bringing its total raised to $9 million. The round was led by Gonpo Tsering along with ultra-high-net individuals (HNIs). SafeHouse plans to utilize the fresh capital to support its growth initiatives in India and fuel …
ngrok, San Francisco, CA-based API-first ingress-as-a-service platform, announced that it closed $50 million in Series A funding. The round was led by Lightspeed Venture Partners with participation from Coatue. With its first fundraiser and after widespread organic adoption, ngrok will scale to meet the increasing demand for its simplified, API-first …
Well iQ, a San Diego, CA-based comprehensive online patient engagement platform, announced that it closed Series A funding. The round was led by Western New York Venture Association/Buffalo Angel. Well, iQ is also pleased to announce the addition of two physician Advisors/Investors to the Board of Directors, Dr. Jason M.Matuszak …
Katonic.ai, a Sydney, Australia-based enterprise machine learning operations (MLOps) platform startup, announced that it raised $1.6 million in a pre-Series funding round led by Artesian, with support from Boab AI. The funding will enable Katonic to expand its products and services, hire additional talent, and grow its customer base. Furthermore, …
PVmed, a Guangzhou, China-based global artificial intelligence (AI) cancer treatment company, secured $$14 million (RM 100 million) in Series A funding. The investment was from investors including Cherami Investment Group, Philips, JHF Investment, COCOCAPITAL Corporation, and Strategy Capital. The funding will enable the company to further develop its AI cancer …
